Patent Application
Provisional
App. No. 63/290,066
· Confirmation No. 3875
CRYSTALLINE FORMS OF A RIPK1 INHIBITOR
Applicant:
Rigel Pharmaceuticals, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-12-28 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2021-12-16 | TR.PROV |
Provisional Cover Sheet (SB16) | 3 | View | |
| 2021-12-16 | ADS |
Application Data Sheet | 9 | View | |
| 2021-12-16 | SPEC |
Specification | 18 | View | |
| 2021-12-16 | CLM |
Claims | 4 | View | |
| 2021-12-16 | ABST |
Abstract | 1 | View | |
| 2021-12-16 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-12-16 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 25885
- Docket No.
- P23061
- Confirmation No.
- 3875
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/290,066
- Filed
- 2021-12-16
External Links